Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of LX7101 in subjects with primary open-angle glaucoma or ocular hypertension has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• LX7101

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Primary Open-angle Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED